AI in Mexican Healthcare: A Structural Transformation

In a context of technological acceleration, LLYC presented its strategic vision on the integration of artificial intelligence in the Mexican healthcare system, highlighting that this technology has ceased to be a trend to consolidate as a structural transformation with annual growth close to 50% by 2030. During the Health Summit: What’s Next in Health, the firm brought together key sector players to analyze the challenges and opportunities that are redefining medical care, proposing a transition towards a proactive, predictive, and data-centered model that translates into tangible patient well-being. The event featured the participation of leaders from the pharmaceutical, corporate, and public policy sectors. Discussions focused on how technological innovation and corporate strategies can catalyze structural changes in the Mexican healthcare system, particularly in terms of access, efficiency, and quality of care. On behalf of the host company, Adolfo Corujo, Partner and Global CEO of Marketing Solutions at LLYC, explained that the true value of artificial intelligence lies not only in data processing. He introduced the concept of "contextual intelligence," which allows for the interpretation of patient behavior and needs through tools such as data mining and deep learning. From this perspective, he highlighted that AI enables the analysis of patient discourse, identification of informational barriers, and reduction of gaps that have historically limited timely access to treatment, thereby improving health outcomes. One of the pillars presented during the event was the analysis of the "Digital Patient Journey," which describes how patients seek information before a medical consultation. It was explained that in a period of just one month, using advanced tools, it is possible to map different scenarios associated with specific diseases, allowing sector actors to anticipate behaviors and guide more effective interventions. This approach enables health systems to influence patients' early decisions, promoting timely diagnoses and appropriate medical care. The implementation of artificial intelligence in health is structured around three strategic objectives: early diagnosis, resource optimization, and expanded access. These elements point towards a more efficient, accessible, and patient-centered system. Rafael Escofet, General Director and Global Health Leader at LLYC, emphasized that artificial intelligence does not replace medical staff but amplifies their diagnostic and care capabilities. He explained that, under the growing pressure of healthcare systems, AI acts as a support that improves clinical accuracy and optimizes decision-making. He also projected that in the next five years, this technology will cease to be considered experimental to become a regular component in medical practice, facilitating faster diagnoses and personalized treatments. The projections presented during the event indicate that the evolution of AI will advance towards personalized care models where treatments adapt to the individual characteristics of each patient. This approach will also contribute to a more efficient management of hospital resources, reducing pressure on healthcare systems and improving the quality of care. The comprehensive analysis of the Health Summit evidenced that artificial intelligence is configuring a new paradigm in the health sector, characterized by the integration of data, technology, and clinical knowledge. In this scenario, the ability to anticipate diseases, optimize processes, and expand access to medical services positions AI as a central element in the evolution of the Mexican healthcare system.